Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2024-11-07

SEC-registered investment adviser since 2023 · limited liability company

As an employer

$631.6m reported value +2.7% vs Q2 2024
38positions
39.3%in top 10
13 new 6 added 19 reduced 11 sold out vs Q2 2024

Holdings, Q3 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NUVALENT INC COM COM 359,114 $36.7m5.82% 5.82% AddedShares held: Q4 2023 255.9k, Q1 2024 265.9k, Q2 2024 252.3k, Q3 2024 359.1k +106.8k +106,838 42.4%
2 ARGENX SE SPONSORED ADR ARGX ARGX 54,440 $29.5m4.67% 4.67% ReducedShares held: Q4 2023 83.4k, Q1 2024 80.0k, Q2 2024 80.0k, Q3 2024 54.4k -25.5k -25,538 -31.9%
3 INSMED INC COM PAR $.01 INSM INSM 356,451 $26.0m4.12% 4.12% AddedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 323.4k, Q3 2024 356.5k +33.1k +33,091 10.2%
4 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 647,611 $25.3m4.00% 4.00% ReducedShares held: Q4 2023 836.3k, Q1 2024 958.7k, Q2 2024 703.4k, Q3 2024 647.6k -55.8k -55,787 -7.9%
5 VAXCYTE INC COM PCVX PCVX 211,985 $24.2m3.84% 3.84% ReducedShares held: Q4 2023 357.5k, Q1 2024 260.3k, Q2 2024 260.3k, Q3 2024 212.0k -48.3k -48,296 -18.6%
6 AXSOME THERAPEUTICS INC COM AXSM AXSM 255,294 $22.9m3.63% 3.63% ReducedShares held: Q4 2023 295.4k, Q1 2024 342.2k, Q2 2024 337.2k, Q3 2024 255.3k -82.0k -81,952 -24.3%
7 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,187,165 $22.9m3.62% 3.62% AddedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 640.4k, Q3 2024 1.2m +546.8k +546,776 85.4%
8 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 150,593 $22.5m3.56% 3.56% ReducedShares held: Q4 2023 151.6k, Q1 2024 151.6k, Q2 2024 186.6k, Q3 2024 150.6k -36.0k -35,988 -19.3%
9 NATERA INC COM NTRA NTRA 155,650 $19.8m3.13% 3.13% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 155.7k
10 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 254,800 $18.6m2.95% 2.95% ReducedShares held: Q4 2023 217.4k, Q1 2024 206.7k, Q2 2024 347.3k, Q3 2024 254.8k -92.5k -92,543 -26.6%
11 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 353,376 $18.1m2.86% 2.86% ReducedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 369.3k, Q3 2024 353.4k -15.9k -15,926 -4.3%
12 TRANSMEDICS GROUP INC COM TMDX TMDX 114,247 $17.9m2.84% 2.84% ReducedShares held: Q4 2023 323.2k, Q1 2024 297.4k, Q2 2024 139.8k, Q3 2024 114.2k -25.5k -25,533 -18.3%
13 ARCELLX INC COMMON STOCK ACLX ACLX 214,298 $17.9m2.83% 2.83% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 214.3k
14 BLUEPRINT MEDICINES CORP COM BPMC BPMC 178,929 $16.6m2.62% 2.62% ReducedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 184.9k, Q3 2024 178.9k -6.0k -5,972 -3.2%
15 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 572,928 $16.5m2.61% 2.61% NewShares held: Q4 2023 1.2m, Q1 2024 973.1k, Q2 2024 0, Q3 2024 572.9k
16 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 35,222 $16.4m2.59% 2.59% ReducedShares held: Q4 2023 81.7k, Q1 2024 58.8k, Q2 2024 50.7k, Q3 2024 35.2k -15.5k -15,470 -30.5%
17 BIOHAVEN LTD COM BHVN BHVN 315,816 $15.8m2.50% 2.50% ReducedShares held: Q4 2023 477.3k, Q1 2024 432.3k, Q2 2024 366.0k, Q3 2024 315.8k -50.2k -50,203 -13.7%
18 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 357,003 $15.4m2.45% 2.45% ReducedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 370.0k, Q3 2024 357.0k -13.0k -12,977 -3.5%
19 MERUS N V COM MRUS MRUS 308,014 $15.4m2.44% 2.44% ReducedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 321.9k, Q3 2024 308.0k -13.9k -13,892 -4.3%
20 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,451,037 $14.9m2.35% 2.35% ReducedShares held: Q4 2023 0, Q1 2024 1.1m, Q2 2024 1.5m, Q3 2024 1.5m -64.9k -64,923 -4.3%
21 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 30,254 $14.9m2.35% 2.35% ReducedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 41.9k, Q3 2024 30.3k -11.6k -11,647 -27.8%
22 HARROW INC COM HROW HROW 326,582 $14.7m2.32% 2.32% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 326.6k
23 VERA THERAPEUTICS INC CL A VERA VERA 326,494 $14.4m2.28% 2.28% AddedShares held: Q4 2023 0, Q1 2024 118.3k, Q2 2024 212.9k, Q3 2024 326.5k +113.5k +113,550 53.3%
24 BICARA THERAPEUTICS INC COM BCAX BCAX 562,391 $14.3m2.27% 2.27% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 562.4k
25 GERON CORP COM GERN GERN 3,124,967 $14.2m2.25% 2.25% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 3.1m
26 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 535,092 $13.7m2.16% 2.16% AddedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 413.2k, Q3 2024 535.1k +121.8k +121,849 29.5%
27 ADMA BIOLOGICS INC COM ADMA ADMA 664,985 $13.3m2.10% 2.10% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 665.0k
28 DAY ONE BIOPHARMACEUTICALS I COM COM 947,878 $13.2m2.09% 2.09% NewShares held: Q4 2023 1.7m, Q1 2024 1.3m, Q2 2024 0, Q3 2024 947.9k
29 REPLIGEN CORP COM RGEN RGEN 88,714 $13.2m2.09% 2.09% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 88.7k
30 XENON PHARMACEUTICALS INC COM XENE XENE 325,218 $12.8m2.03% 2.03% ReducedShares held: Q4 2023 680.4k, Q1 2024 680.4k, Q2 2024 339.9k, Q3 2024 325.2k -14.7k -14,658 -4.3%
31 GLAUKOS CORP COM GKOS GKOS 96,097 $12.5m1.98% 1.98% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 96.1k
32 KRYSTAL BIOTECH INC COM KRYS KRYS 67,942 $12.4m1.96% 1.96% ReducedShares held: Q4 2023 242.2k, Q1 2024 130.8k, Q2 2024 109.2k, Q3 2024 67.9k -41.3k -41,280 -37.8%
33 CYTOKINETICS INC COM NEW CYTK CYTK 223,147 $11.8m1.87% 1.87% ReducedShares held: Q4 2023 807.4k, Q1 2024 430.3k, Q2 2024 293.3k, Q3 2024 223.1k -70.2k -70,171 -23.9%
34 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 621,306 $11.5m1.82% 1.82% AddedShares held: Q4 2023 0, Q1 2024 250.9k, Q2 2024 561.0k, Q3 2024 621.3k +60.3k +60,317 10.8%
35 BRIDGEBIO PHARMA INC COM BBIO BBIO 399,781 $10.2m1.61% 1.61% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 399.8k
36 RELAY THERAPEUTICS INC COM RLAY RLAY 1,226,354 $8.7m1.37% 1.37% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 1.2m
37 ARS PHARMACEUTICALS INC COM SPRY SPRY 593,291 $8.6m1.36% 1.36% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 593.3k
38 KALVISTA PHARMACEUTICALS INC COM KALV KALV 355,000 $4.1m0.65% 0.65% ReducedShares held: Q4 2023 0, Q1 2024 1.2m, Q2 2024 1.1m, Q3 2024 355.0k -704.5k -704,540 -66.5%

Sold out since Q2 2024

SecurityTickerShares held beforeValue then
SAREPTA THERAPEUTICS INC SRPT SRPT 181,669 $28.7m181.7k shares
IMMUNOVANT INC IMVT IMVT 695,428 $18.4m695.4k shares
DEXCOM INC DXCM DXCM 160,096 $18.2m160.1k shares
ALPHATEC HLDGS INC ATEC ATEC 1,360,410 $14.2m1.4m shares
IDEAYA BIOSCIENCES INC IDYA IDYA 397,782 $14.0m397.8k shares
REVOLUTION MEDICINES INC RVMD RVMD 329,519 $12.8m329.5k shares
APOGEE THERAPEUTICS INC 318,327 $12.5m318.3k shares
SPYRE THERAPEUTICS INC SYRE SYRE 464,435 $10.9m464.4k shares
SILENCE THERAPEUTICS PLC SLN SLN 537,338 $10.2m537.3k shares
IMMUNOCORE HLDGS PLC IMCR IMCR 291,086 $9.9m291.1k shares
DISC MEDICINE INC IRON IRON 138,907 $6.3m138.9k shares